Is Manhattan Associates Inc (MANH) a risky stock?
As of July 31, 2026, Clavix grades Manhattan Associates Inc (MANH) B for risk, a composite score of 73 out of 100 on an A+ to F scale, which puts MANH in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 31, 2026. Clavix regrades every trading day.
The five risk dimensions behind MANH's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how MANH scores on each, as of July 31, 2026.
What's moving MANH's risk right now
Company-specific signals Clavix flags behind MANH's current grade, drawn from recent news and filings as of July 31, 2026.
Manhattan Associates’ latest earnings reveal a company firing on all cylinders: cloud revenue skyrocketed 26% year-on-year, while record quarterly bookings and rising RPO undersco…
New capability reveals the reasoning behind every AI-driven forecast, recommendation, and inventory decision in ActivePlanning, deepening planner trust by turning hours of off-sys…
Recent MANH news
The latest headlines Clavix ingested for Manhattan Associates Inc, newest first. These feed the news-sentiment dimension of MANH's grade.
What a B grade means
On the Clavix A+ to F scale, MANH's composite of 73 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell MANH or any security. Grades are risk indicators, not predictions of return. Data may be delayed.